These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26657416)

  • 21. Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders.
    Youdim MB; Buccafusco JJ
    Trends Pharmacol Sci; 2005 Jan; 26(1):27-35. PubMed ID: 15629202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of zinc in the pathogenesis and treatment of central nervous system (CNS) diseases. Implications of zinc homeostasis for proper CNS function.
    Tyszka-Czochara M; Grzywacz A; Gdula-Argasińska J; Librowski T; Wiliński B; Opoka W
    Acta Pol Pharm; 2014; 71(3):369-77. PubMed ID: 25265815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alkynyl-coumarinyl ethers as MAO-B inhibitors.
    Mertens MD; Hinz S; Müller CE; Gütschow M
    Bioorg Med Chem; 2014 Mar; 22(6):1916-28. PubMed ID: 24560738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 8-Substituted 3-arylcoumarins as potent and selective MAO-B inhibitors: synthesis, pharmacological evaluation, and docking studies.
    Viña D; Matos MJ; Ferino G; Cadoni E; Laguna R; Borges F; Uriarte E; Santana L
    ChemMedChem; 2012 Mar; 7(3):464-70. PubMed ID: 22287164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
    Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
    Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic and natural coumarins as cytotoxic agents.
    Kostova I
    Curr Med Chem Anticancer Agents; 2005 Jan; 5(1):29-46. PubMed ID: 15720259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depressive effects on the central nervous system and underlying mechanism of the enzymatic extract and its phlorotannin-rich fraction from Ecklonia cava edible brown seaweed.
    Cho S; Han D; Kim SB; Yoon M; Yang H; Jin YH; Jo J; Yong H; Lee SH; Jeon YJ; Shimizu M
    Biosci Biotechnol Biochem; 2012; 76(1):163-8. PubMed ID: 22232271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel monoamine oxidase inhibitors: a patent review (2012 - 2014).
    Carradori S; Petzer JP
    Expert Opin Ther Pat; 2015 Jan; 25(1):91-110. PubMed ID: 25399762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoamine oxidase A and B inhibiting effect and molecular modeling of some synthesized coumarin derivatives.
    Abdelhafez OM; Amin KM; Ali HI; Abdalla MM; Batran RZ
    Neurochem Int; 2013 Jan; 62(2):198-209. PubMed ID: 23182697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Phytosterols on the Healthy and Diseased Brain.
    Dierckx T; Bogie JFJ; Hendriks JJA
    Curr Med Chem; 2019; 26(37):6750-6765. PubMed ID: 29984647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of neurotensin in central nervous system pathophysiology: what is the evidence?
    St-Gelais F; Jomphe C; Trudeau LE
    J Psychiatry Neurosci; 2006 Jul; 31(4):229-45. PubMed ID: 16862241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of monoamine oxidases by coumarin-3-acyl derivatives: biological activity and computational study.
    Chimenti F; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3697-703. PubMed ID: 15203146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of deficiency of pantothenic acid and pyridoxine on the function of the central nervous system and its response to coumarin from Melilotus officinalis].
    Földi M; Zoltán OT
    Arzneimittelforschung; 1970 Nov; 20(11):Suppl 11a:1618+. PubMed ID: 5536960
    [No Abstract]   [Full Text] [Related]  

  • 34. [Monoamine oxidase as a target for drug action].
    Drozak J; Kozłowski M
    Postepy Hig Med Dosw (Online); 2006; 60():498-515. PubMed ID: 17060892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent Highlights on Molecular Hybrids Potentially Useful in Central Nervous System Disorders.
    Matias M; Silvestre S; Falcao A; Alves G
    Mini Rev Med Chem; 2017; 17(6):486-517. PubMed ID: 27834131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the antioxidant activity of several naturally occurring coumarins and their synthesized analogues by "ferric reducing antioxidant power" assay.
    Rehakova Z; Koleckar V; Jahodar L; Opletal L; Macakova K; Cahlikova L; Jun D; Kuca K
    J Enzyme Inhib Med Chem; 2014 Feb; 29(1):49-54. PubMed ID: 23356333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues.
    Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP
    Bioorg Chem; 2015 Apr; 59():117-23. PubMed ID: 25746740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adult neurogenesis pharmacology in neurological diseases and disorders.
    Taupin P
    Expert Rev Neurother; 2008 Feb; 8(2):311-20. PubMed ID: 18271715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phytochemical investigation of some traditional chinese medicines and endophyte cultures.
    Tan RX; Meng JC; Hostettmann K
    Pharm Biol; 2000; 38 Suppl 1():25-32. PubMed ID: 23531135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coumarin hybrids as novel therapeutic agents.
    Sandhu S; Bansal Y; Silakari O; Bansal G
    Bioorg Med Chem; 2014 Aug; 22(15):3806-14. PubMed ID: 24934993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.